Skip to main content
Matty Rypto Photo
Mahathir Bayena

Mahathir Bayena

GrafaCrypto Journalist

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.

Articles by Mahathir Bayena

Grafa

AN2 Therapeutics reports positive efficacy data for Chagas disease candidate

AN2 Therapeutics (NASDAQ:ANTX) announced positive data today from two separate studies evaluating its investigational oral CPSF3 inhibitor, AN2-502998, for the treatment of chronic Chagas disease—a parasitic condition caused by Trypanosoma cruzi that affects millions globally.

Read more: AN2 Therapeutics reports positive efficacy data for Chagas disease candidate